![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Canada | Publication | March 24, 2020 - 7 PM ET
The OSC’s order provides for certain temporary exemptions for investment funds, including:
(a) such that certain filing and delivery obligations of investment funds are extended for a period of 45 days from the original required filing date, where the delivery deadlines fall during the period from March 23, 2020 to June 1, 2020; and
(b) such that investment funds distributing securities under a prospectus with a lapse date during the period from March 23, 2020 to June 1, 2020, have the lapse date extended for a period of 45 days.
In order to rely on this relief, an investment fund must, in advance of the original filing or delivery deadline, notify the Director of the Investment Funds and Structured Products Branch (IFSPDirector@osc.gov.on.ca) that the investment fund is relying on this relief and must specify each applicable requirement for which it is relying on this relief. Additionally, an investment fund relying on this relief must, in advance of its filing or delivery deadline, post a statement on its public website, or the public website of its investment fund manager, stating that the investment fund is relying on this relief and each applicable requirement for which it is relying on this relief.
For a list of the filing and delivery obligations for which exemptive relief is being given, reference is made to (a) Ontario Instrument 31-510 – Temporary Exemption from Certain Financial Statement and Information Delivery Requirements for Registrants and Unregistered Capital Markets Participants; and (b) Ontario Instrument 81-503 – Extension of Certain Filing, Delivery and Prospectus Renewal Requirements of Investment Funds, which can be found here and here.
Should you have any questions on the implementation of any of the above or questions about ongoing filing obligations, do not hesitate to contact our team.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023